Finance

Lists
4552:TYO
JCR Pharmaceuticals Co Ltd
¥489.00
+3.82%
(+18.00) 1D
Aug 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4552...
Open
¥470
High
¥491
Low
¥468
Mkt. cap
63.42B
Avg. vol.
633.18K
Volume
665.50K
Dividend
4.09%
Quarterly dividend
¥5
Ex-dividend date
Sep 29, 2026
P/E ratio
72.93
52-wk high
¥824
52-wk low
¥444
EPS
¥7
Shares outstanding
30.79M
No. of employees
985
Open
¥470
High
¥491
Low
¥468
Mkt. cap
63.42B
Avg. vol.
633.18K
Volume
665.50K
Dividend
4.09%
Quarterly dividend
¥5
Ex-dividend date
Sep 29, 2026
P/E ratio
72.93
52-wk high
¥824
52-wk low
¥444
EPS
¥7
Shares outstanding
30.79M
No. of employees
985
News stories
From sources across the web
About JCR Pharmaceuticals Co Ltd
CEO-
Employees985
FoundedSep 13, 1975
Headquarters-
SectorPharmaceutical industry
Websitejcrpharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.79B
8.99B
9.97B
9.70B
Cost of goods sold
1.97B
2.39B
3.42B
2.25B
Cost of revenue
1.97B
2.39B
3.42B
2.25B
Research and development expenses
-
-
16.76B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.84B
8.50B
-10.29B
9.55B
Operating expense
7.88B
8.54B
6.48B
9.55B
Total operating expenses
9.85B
10.93B
9.90B
11.80B
Operating income
2.95B
-1.94B
66.00M
-2.10B
Other non operating income
32.00M
49.00M
-65.00M
135.00M
EBT including unusual items
3.29B
281.00M
402.00M
-2.08B
EBT excluding unusual items
3.07B
-1.64B
28.00M
-2.08B
Income tax expense
1.01B
157.00M
27.00M
-166.00M
Effective tax rate
30.79%
55.87%
6.72%
7.97%
Other operating expenses
-
-
-
-
Net income
2.26B
69.00M
399.00M
-1.91B
Net profit margin
17.63%
0.77%
4.00%
-19.66%
Earnings per share
-
-
-
-
Interest and investment income
30.00M
33.00M
27.00M
23.00M
Interest expense
-78.00M
-151.00M
-90.00M
-157.00M
Net interest expenses
-48.00M
-118.00M
-63.00M
-134.00M
Depreciation and amortization charges
39.00M
36.00M
12.00M
-
EBITDA
3.68B
-1.09B
705.25M
-1.46B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps